Pricing Log in Create free account

NeoGenomics, Inc. (NEO) vs GeneDx Holdings Corp. (WGS)

NeoGenomics, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. NeoGenomics, Inc. is the larger, with a market value of $2.1B against $1.9B — 1.1× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 11.1%. NeoGenomics, Inc. has the higher net margin (−4.10% vs −23.4%) and the higher return on invested capital (−2.97% vs −27.7%). Across the 18 metrics below, NeoGenomics, Inc. leads on 12 and GeneDx Holdings Corp. on 6.

Valuation

Metric NEO WGS Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.70 4.24 4.24
P/B 2.66 7.89 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA 146.75 n/m 23.44
EV/Sales 3.26 4.16 5.18
Earnings yield (1.50%) (5.61%) (1.50%)
Free cash flow yield (1.25%) (3.93%) 0.00%

Profitability

Metric NEO WGS Diagnostics & Research median
Gross margin 44.77% 69.37% 48.32%
Operating margin (6.27%) (20.34%) (5.68%)
Net margin (4.10%) (23.40%) (4.10%)
Free cash flow margin (3.37%) (16.68%) 0.00%
Return on equity (3.94%) (40.80%) 0.00%
Return on assets (2.35%) (22.50%) (6.05%)
Return on invested capital (2.97%) (27.70%) 0.00%

Growth

Metric NEO WGS Diagnostics & Research median
Revenue growth (TTM) 11.08% 25.42% 8.99%
EPS growth (last fiscal year) (35.48%) 62.37% 20.36%
Revenue growth, 5-year CAGR 10.35% 18.98% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEO WGS Diagnostics & Research median
Debt to equity 0.47 0.40 0.01
Current ratio 3.53 3.30 2.27
Net debt to EBITDA (3.96) (10.13) 0.68

Dividend

Metric NEO WGS Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric NEO WGS Diagnostics & Research median
Market cap 2.13b 1.92b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack